期刊文献+

初诊肺栓塞延迟诊断影响因素的分析 被引量:1

下载PDF
导出
摘要 目的评估在初诊中肺栓塞(PE)诊断延迟的程度,确定诊断延迟相关的影响因素。方法回顾性分析2012年1月至2016年12月急诊科就诊的并最后确诊为肺栓塞患者,收集患者PE延迟诊断时间等临床资料。通过多因素logistic回归模型分析影响延迟诊断的因素。结果在总共1474例PE患者中,121例患者在1个月内PE相关症状而就诊,其中约24.0%存在诊断延迟。高龄和胸部症状缺失是诊断延迟的独立影响因素。而在非延迟诊断患者中伴随COPD和或哮喘率为14.1%,而在延迟诊断患者中占379%(P=0.013)。结论在初诊中,肺栓塞延迟诊断的情况仍较普遍,尤其是在老年人和胸部症状缺失的情况下。因此,初诊时需要时刻注意细节,更要在非典型患者中考虑肺栓塞诊断的可能。 Objective To assess the extent of delayed diagnosis of pulmonary embolism ( PE ) in primary care and to identify the factors associated with delayed diagnosis. Methods The clinical data of PE patients were collected and analyzed retrospectively from January 2012 to December 2016 at the emergency department, and time of diagnosis delay were documented. Multivariable logistic regression analysis was performed to identify independent determinants for delayed diagnosis. Results In total, 147 CTPA-confirmed PE cases were identified, of whom 121 patients had 1 or more potential PE-related contact with their doctor within the 1 month prior to the diagnosis. Based on our definition, in 29 of these patients (24.0 % ) , diagnostic delay was observed. Older age and the absence of chest symptoms were two independent determinants for the diagnostic delay. A history of COPD and/or asthma prior to the PE diagnosis was reported in 14.1% of cases without delay, and in 37.9% of patients with delay ( P=0.013 ) . Conclusion Diagnostic delay in the diagnosis of PE is common in primary care, especially in the elderly patients without chest symptoms. Therefore, we must pay attention to the details of patients' presentations at all times, and consider the possibility of pulmonary embolism in atypical patients.
作者 余贤兴
出处 《浙江临床医学》 2018年第8期1377-1378,1384,共3页 Zhejiang Clinical Medical Journal
关键词 肺栓塞 诊断延迟 LOGISTIC回归模型 Pulmonary embolism Delayed diagnosis Logistic regression model
  • 相关文献

参考文献2

二级参考文献55

  • 1荆志成,邓可武.急性肺动脉血栓栓塞症的溶栓治疗[J].中华医学杂志,2004,84(22):1932-1934. 被引量:20
  • 2邹治鹏,何建国,程显声,赵彦芬,陈白屏,高莹,熊长明,倪新海,荆志诚.230例急性肺动脉血栓栓塞症患者对症治疗、抗凝治疗和溶栓治疗的住院转归[J].中国循环杂志,2006,21(3):219-221. 被引量:27
  • 3Yalamanchili K, Fleisher AG, Lehrman SG, et al. Open pulmonary embolectomy for treatnlent of major pulmonary embolism. Ann Thorae Surg, 2004,77:819-823.
  • 4Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood Rev, 2005, 19 : 179-202.
  • 5PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d' Embolie Pulmonaire par Interruption Cave) randomized study. Circulation, 2005,112:416-422.
  • 6Karmy-Jones R, Jurkovich GJ, Velmahos GC, et al. Practice patterns and outcomes of retrievable vena cava filters in trauma patients : an AAST multicenter study. J Trauma, 2007,62 : 17-24.
  • 7Barral FG. Vena cava filters: why, when, what and how? J Cardiovasc Surg (Torino) , 2008,49:35-49.
  • 8Meyer G, Sors H, Charbonnier B, et al. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism : a European nmlticenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol, 1992, 19:239-245.
  • 9Dalla-Volta S, Palla A, Santolicandro A, et al. PALMS 2: aheplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. J Am Coll Cardiol, 1992, 20:520-526.
  • 10Levine M, Hirsh J, Weitz J, et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest, 1990, 98: 1473-1479.

共引文献501

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部